Acquisitions (Narrative) (Details) (USD $) | 0 Months Ended | 3 Months Ended | ||||
|---|---|---|---|---|---|---|
Jan. 14, 2011
Arresto Biosciences, Inc. [Member] | Dec. 31, 2010
Arresto Biosciences, Inc. [Member] | Mar. 31, 2011
Calistoga Pharmaceuticals, Inc. [Member] | Apr. 02, 2011
Calistoga Pharmaceuticals, Inc. [Member] | Feb. 28, 2011
Calistoga Pharmaceuticals, Inc. [Member] | Sep. 30, 2011
Oceanside Research And Clinical Manufacturing Facility [Member] | |
| Business Acquisition [Line Items] | ||||||
| Fair value of consideration transferred for business acquisition | $ 225,000,000 | $ 375,000,000 | ||||
| Potential payments based on the achievement of milestones | 225,000,000 | |||||
| Acquisition-date fair value of total consideration transferred to acquire company | 227,100,000 | 484,300,000 | ||||
| Total cash paid for acquisition | 221,700,000 | 373,700,000 | 28,300,000 | |||
| Contingent consideration paid | 5,400,000 | 110,600,000 | ||||
| Acquisition-date fair value of intangible assets | 117,000,000 | 149,200,000 | ||||
| Present value discount rate | 16.00% | 11.00% | ||||
| Fair values assigned to the assets acquired and liabilities assumed | 227,069,000 | 484,298,000 | ||||
| Goodwill resulting from acquisition | $ 134,482,000 | $ 336,951,000 | $ 336,951,000 |
| X | ||||||||||
- Definition The aggregate amount assigned to a major class of finite-lived intangible assets acquired either individually or as part of a group of assets (in either an asset acquisition or business combination). A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Fair value, as of the acquisition date, of potential payments under the contingent consideration arrangement including cash and shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of potential cash payments that could result from the contingent consideration arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of cash paid to acquire the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The total cost of the acquired entity including the cash paid to shareholders of acquired entities, fair value of debt and equity securities issued to shareholders of acquired entities, the fair value of the liabilities assumed, and direct costs of the acquisition. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
|
| X | ||||||||||
- Definition The total purchase price of the acquired entity. This includes cash paid to equity interest holders of the acquired entity, fair value of debt and equity securities issued to equity holders of the acquired entity, and transaction costs paid to third parties to consummate the acquisition. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of goodwill arising from a business combination, which is the excess of the cost of the acquired entity over the amounts assigned to assets acquired and liabilities assumed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This element represents the acquisition-date fair value of the total consideration transferred which consists of the sum of the acquisition-date fair values of the assets transferred by the acquirer, the liabilities incurred by the acquirer to former owners of the acquiree, and the equity interests issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The discount rate used to estimate the fair value of servicing assets and servicing liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|